Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.15)
# 2,912
Out of 5,005 analysts
346
Total ratings
38.76%
Success rate
-3.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $67.74 | +18.10% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $68.98 | +8.73% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $69.15 | -6.00% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $4.02 | +248.26% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $46.22 | +116.36% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $19.79 | +127.39% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $32.06 | +133.94% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $13.66 | +119.62% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $21.43 | +105.32% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $22.64 | -55.83% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $17.75 | -43.66% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $19.96 | +50.30% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $18.10 | +590.61% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $13.40 | +11.94% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.23 | +306.50% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $5.52 | -9.42% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.30 | +51.52% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $6.62 | +126.59% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $22.34 | +101.43% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $3.92 | -23.47% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $10.19 | +292.54% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.56 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $2.65 | +164.15% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $3.93 | -23.66% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.51 | +289.64% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.51 | +1,682.18% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.41 | +177.26% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.26 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $0.73 | +83,664,692.21% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.83 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $67.74
Upside: +18.10%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $68.98
Upside: +8.73%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $69.15
Upside: -6.00%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $4.02
Upside: +248.26%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $46.22
Upside: +116.36%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $19.79
Upside: +127.39%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $32.06
Upside: +133.94%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $13.66
Upside: +119.62%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $21.43
Upside: +105.32%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $22.64
Upside: -55.83%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $17.75
Upside: -43.66%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $19.96
Upside: +50.30%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $18.10
Upside: +590.61%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $13.40
Upside: +11.94%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.23
Upside: +306.50%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $5.52
Upside: -9.42%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $3.30
Upside: +51.52%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $6.62
Upside: +126.59%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $22.34
Upside: +101.43%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $3.92
Upside: -23.47%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $10.19
Upside: +292.54%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $2.65
Upside: +164.15%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $3.93
Upside: -23.66%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.51
Upside: +289.64%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.51
Upside: +1,682.18%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.41
Upside: +177.26%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.26
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $0.73
Upside: +83,664,692.21%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $4.83
Upside: -